Allogeneic transplantation of recipients at high risk of graft versus host disease using CD34 positive cells selected from peripheral blood or bone marrow.

被引:0
|
作者
Durrant, STS [1 ]
Hutchins, CJ [1 ]
James, K [1 ]
Seeley, G [1 ]
Taylor, K [1 ]
Lockwood, L [1 ]
机构
[1] ROYAL BRISBANE HOSP,BONE MARROW TRANSPLANT UNIT,BRISBANE,QLD 4029,AUSTRALIA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:4403 / 4403
页数:1
相关论文
共 50 条
  • [41] GRAFT-VERSUS-HOST DISEASE IN EXPERIMENTAL ALLOGENEIC BONE-MARROW TRANSPLANTATION
    KORNGOLD, R
    SPRENT, J
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1991, 197 (01): : 12 - 18
  • [42] Prevention of graft-versus-host-disease by transplantation of allogeneic CD34(+) blood cells additionally T-cell depleted with Compath-1H.
    Hertenstein, B
    Arseniev, L
    Novotny, J
    Battmer, K
    Stucki, A
    Sudmeier, I
    Pappe, I
    Kadar, JG
    Hale, G
    Waldman, H
    Ganser, A
    BLOOD, 1996, 88 (10) : 3775 - 3775
  • [43] P-Selectin in Recipients of Allogeneic Bone Marrow Transplantation Regulates Experimental Graft-Versus-Host-Disease.
    Lu, Sydney X.
    Palomba, Maria Lia
    Na, Il-Kang
    Terwey, Theis
    Alpdogan, Onder
    Bautista, Jhoanne L.
    Smith, Marsinay O.
    Suh, David
    King, Christopher
    Rao, Uttam
    Yim, Nury
    Jenq, Robert R.
    Zakrzewski, Johannes L.
    Holland, Amanda M.
    Penack, Olaf
    Dykstra, Lindsay
    Bampoe, Kevin
    van den Brink, Marcel R. M.
    BLOOD, 2009, 114 (22) : 546 - 546
  • [44] AUTOLOGOUS BONE-MARROW TRANSPLANTATION WITH CD34 POSITIVE SELECTED CELLS IN PATIENTS WITH NON-HODGKINS-LYMPHOMA
    DOUAY, L
    LOPEZ, M
    LAPORTE, IP
    OUITTET, PH
    LESAGE, S
    GORIN, NC
    EXPERIMENTAL HEMATOLOGY, 1993, 21 (08) : 1066 - 1066
  • [45] Allogeneic transplantation of CD34+ selected or unselected peripheral blood progenitor cells
    Finke, J
    Bertz, H
    Afting, M
    Behringer, D
    Berger, C
    Heidecker, L
    Kunzmann, R
    Marks, R
    Potthoff, K
    Wäsch, R
    Winkler, J
    Mertelsmann, R
    BONE MARROW TRANSPLANTATION, 1998, 22 : S8 - S8
  • [46] CD34 POSITIVE CELL-SEPARATION FOR AUTOLOGOUS BONE-MARROW AND BLOOD TRANSPLANTATION
    DOUAY, L
    BOCCACCIO, C
    LOPEZ, M
    BONY, V
    BOUCHET, S
    ZAPPAVIGNA, S
    GOSSET, AC
    ROZENBAUM, H
    GORIN, NC
    EXPERIMENTAL HEMATOLOGY, 1992, 20 (06) : 738 - 738
  • [47] Haematopoietic reconstitution after autologous transplantation of CD34(+)-selected versus non-selected peripheral blood progenitor cells
    Wiesneth, M
    Schreiner, T
    Sandherr, M
    Maccari, B
    Erne, E
    Bischof, C
    Frickhofen, N
    vonSchilling, C
    Kubanek, B
    TRANSFUSIONSMEDIZIN 1996/97, 1997, 34 : 133 - 138
  • [48] CD34 Selected Cells for the Treatment of Poor Graft Function after Allogeneic Stem Cell Transplantation
    Stasia, Alessandra
    Ghiso, Anna
    Galaverna, Federica
    Raiola, Anna Maria
    Gualandi, Francesca
    Luchetti, Silvia
    Pozzi, Sarah
    Varaldo, Riccardo
    Lamparelli, Teresa
    Bregante, Stefania
    Van Lint, Maria Teresa
    di Grazia, Carmen
    Bacigalupo, Andrea
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (09) : 1440 - 1443
  • [49] Cataract surgery in allogeneic bone marrow transplant recipients with graft-versus-host disease
    Penn, EA
    Soong, HK
    JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 2002, 28 (03): : 417 - 420
  • [50] The Impact of CD3 And CD34 Cell Dose on Graft Rejection And Graft Versus Host Disease in Children Undergoing Unrelated Peripheral Blood Stem Cell Transplantation
    Meena, Satish
    Varla, Harika
    Chandar, Rumesh
    Swaminathan, Venkateswaran Vellaichamy
    Ramakrishnan, Balasubramanium
    Uppuluri, Ramya
    Jayakumar, Indira
    Raj, Revathi
    BONE MARROW TRANSPLANTATION, 2021, 56 (SUPPL 1) : 90 - 91